GBI Research

GBI Research provides industry-leading global business intelligence solutions. Our products and services help companies make better business decisions, win business and position themselves more effectively. GBI Research publishes more than 100 research reports per annum across a wide range of industries. Our reports draw on in-depth primary and secondary research, databases of proprietary in-house data and high quality analysis from our expert teams. GBI Research employs hundreds of highly qualified Analysts across the US, Europe and Asia. Key report types currently published by GBI Research include:

 

  • Market Intelligence Reports: premium analytical reports based on a combination of market data, company, deals and project content, industry surveys and additional primary and secondary research.
  • Benchmarking Reports: analytical reports comparing key financial indicators for the top 20 companies in a particular industry and geography.
  • Industry Outlook Reports: survey-based reports, revealing and analyzing the leading experts' opinions on the future of the industry covered.
  • Market Profiles: overview-level reports based on market, company and demographic data.
  • Pipeline Analysis Reports: reports analyzing the unmet need, market size and product pipeline for different disease indications, based on a detailed database of developmental products.
GBI Research
 

List of reports from GBI Research

2  3  4  5    7    9  10  11  
Statins Market to 2018 - Weak Product Pipeline and Shift of Focus towards Combination Therapies will Lead to Erosion of Brand Share
1/22/2013 | published by: GBI Research
... “Statins Market to 2018 - Weak Product Pipeline and Shift of Focus towards Combination Therapies will Lead to Erosion of Brand Share”, which provides insights into the global statins market until 2018. The report is ...  |  read more...
USD 3,500
Indian Pharmaceutical Market Outlook - Enhanced purchasing power, rural market penetration and expanded access to healthcare attracting Big Pharma investment
1/22/2013 | published by: GBI Research
... penetration and expanded access to healthcare attracting Big Pharma investment” provides in-depth analysis of the trends, issues and challenges facing the Indian pharmaceutical market. It is built using data and information sourced from proprietary databases, ...  |  read more...
USD 3,500
Offshore Rig Construction Market to 2016 and Current Rig Deployment Scenario - Rig Designs Promoting Better Safety Conformation and Increased Operational Capabilities being Key to Newbuild Orders
1/22/2013 | published by: GBI Research
... provider, has released its latest research, “Offshore Rig Construction Market to 2016 and Current Rig Deployment Scenario - Rig Designs Promoting Better Safety Conformation and Increased Operational Capabilities being Key to Newbuild Orders”. The study, ...  |  read more...
USD 3,500
Opioids Market to 2018 - Increasing Concentration of Abuse-Resistant Branded Generics Alter Competitive Dynamics in this Flat Market
1/4/2013 | published by: GBI Research
... 2018 - Increasing Concentration of Abuse-Resistant Branded Generics Alter Competitive Dynamics in this Flat Market”. The current opioids market is characterized by a very broad and highly diversified product portfolio. Patients experiencing moderate to severe ...  |  read more...
USD 3,500
Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail
12/31/2012 | published by: GBI Research
... latest research report, entitled: “Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail”. The report provides insights into the ...  |  read more...
USD 3,500
Mobile Health (mHealth) - Enhancing Healthcare and Improving Clinical Outcomes
12/14/2012 | published by: GBI Research
... report examines how mHealth, which is the facilitation of health-related information through mobile-enabled technologies, has been applied by the pharmaceutical industry in drug development and by healthcare providers in the developed and emerging economies to ...  |  read more...
USD 3,500
Stem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity
12/14/2012 | published by: GBI Research
... Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity”. The report provides an in-depth analysis on stem cell research and development in India, China, ...  |  read more...
USD 3,500
Innovation in the Prefilled Syringe Market - Biologics and Autoinjection Devices Shaping Future R&D Trends
12/14/2012 | published by: GBI Research
... Biologics and Autoinjection Devices Shaping Future R&D Trends”, which provides insights into possible future avenues of R&D in the prefilled syringe market. This includes an overview of problems and possible solutions, as well as discussion ...  |  read more...
USD 3,500
Caprolactam Global Market to 2020 - Growth driven by Rising Demand from Nylon Fiber and Resin and Films Applications in China
12/14/2012 | published by: GBI Research
... from Nylon Fiber and Resin and Films Applications in China’ is an in-depth report focusing on the demand side of the global caprolactam industry. The report provides the reader with detailed analysis and forecasts of ...  |  read more...
USD 3,500
Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs
12/14/2012 | published by: GBI Research
... Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs”. The report provides a comprehensive overview of the generic drugs market in the US, the top five ...  |  read more...
USD 3,500
Rheumatology Therapeutics Market to 2018 - Increasing Uptake of Benlysta, Uloric, Krystexxa, and the Launch of Oral Tofacitinib to Spur Growth
12/14/2012 | published by: GBI Research
... Therapeutics Market to 2018 - Increasing Uptake of Benlysta, Uloric, Krystexxa, and the Launch of Oral Tofacitinib to Spur Growth”. The report provides insights into the rheumatology therapeutics market forecasts until 2018 and examines global ...  |  read more...
USD 3,500
Joint Reconstruction (Hip and Knee Devices) Market to 2018 - Advanced Implant Materials, Innovative Designs and Improved Longevity lead to Rise in the Number of Early Joint Replacement Surgeries
12/3/2012 | published by: GBI Research
... (Hip and Knee Devices) Market to 2018 - Advanced Implant Materials, Innovative Designs and Improved Longevity lead to Rise in the Number of Early Joint Replacement Surgeries” provides key data, information and analysis for the ...  |  read more...
USD 3,500
Patient Adherence, Communication and Engagement (PACE) - Increased Investment and Adoption of New Digital Tools Enable Key Stakeholder Collaborations and Encourage Compliance
11/30/2012 | published by: GBI Research
... “Patient Adherence, Communication and Engagement (PACE) - Increased Investment and Adoption of New Digital Tools Enable Key Stakeholder Collaborations and Encourage Compliance”. The report focuses on the US health system’s efforts to improve patient engagement ...  |  read more...
USD 3,500
OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Expanded Access, Aging Populations and Increasing Obesity Levels to Drive Future Growth
11/30/2012 | published by: GBI Research
... Pharmaceuticals and Self-medication in Seven Emerging Markets - Expanded Access, Aging Populations and Increasing Obesity Levels to Drive Future Growth”, which provides insights into the up-and-coming trends of the Over the Counter (OTC) pharmaceutical market ...  |  read more...
USD 3,500
Contraceptives Market to 2018 - Safety Concerns Plague Drospirenone-containing Birth Control Pills and Long-term Use of Estrogen
11/9/2012 | published by: GBI Research
... Safety Concerns Plague Drospirenone-containing Birth Control Pills and Long-term Use of Estrogen”, which provides insights into the global contraceptives market and market forecasts until 2018. The report provides an in-depth analysis of the most commonly ...  |  read more...
USD 3,500
Parenteral Nutrition Market to 2018 - Rising Incidence of Chronic Diseases such as Cancer, AIDS and Gastrointestinal (GI) Disorders, and Increased Use of Specialty Drugs Drive Growth
11/9/2012 | published by: GBI Research
... has released its latest research, “Parenteral Nutrition Market to 2018 - Rising Incidence of Chronic Diseases such as Cancer, AIDS and Gastrointestinal (GI) Disorders, and Increased Use of Specialty Drugs Drive Growth”. It provides in-depth ...  |  read more...
USD 3,500
Women’s Health Therapeutics Market to 2018 - Unmet Need for Safe and Effective Treatments due to Unfavorable Risk/Benefit Profile Associated with Hormone Replacement Therapy
11/9/2012 | published by: GBI Research
... latest research, “Women’s Health Therapeutics Market to 2018 - Unmet Need for Safe and Effective Treatments due to Unfavorable Risk/Benefit Profile Associated with Hormone Replacement Therapy”, which provides insights into the women’s health therapeutics market ...  |  read more...
USD 3,500
Drug Discovery and Development Market in Asia - Partnerships Between MNCs and Asian Academic Institutions and Healthcare Research Organizations are Driving R&D Innovation
11/9/2012 | published by: GBI Research
... research, “Drug Discovery and Development Market in Asia - Partnerships Between MNCs and Asian Academic Institutions and Healthcare Research Organizations are Driving R&D Innovation”. The report provides key data, information and analysis of the major ...  |  read more...
USD 3,500
Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes
11/9/2012 | published by: GBI Research
... Companion Diagnostics to Optimize Therapeutic Outcomes” provides information and analysis on the major trends and issues affecting biomarkers in the drug discovery process. The report describes the history of biomarkers and their role in fulfilling ...  |  read more...
USD 3,500
Cell Culture - Rising Demand for Biologics and Growing Visibility of Approval Pathway for Biosimilars will Create Growth Opportunities
11/9/2012 | published by: GBI Research
... Rising Demand for Biologics and Growing Visibility of Approval Pathway for Biosimilars will Create Growth Opportunities”, which provides in-depth analysis on the processes, drivers and barriers of the cell culture market. The report analyzes the ...  |  read more...
USD 3,500
Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand
11/9/2012 | published by: GBI Research
... - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand” provides detailed insight into the global APIs market. The research presents detailed analysis and forecasts of the major economic and ...  |  read more...
USD 3,500
HIV/AIDS Therapeutics Market to 2018 - Despite Major Patent Expiries, Increased Uptake of Once-a-Day Fixed-dose Combination Drugs to Drive Growth
11/9/2012 | published by: GBI Research
... Market to 2018 - Despite Major Patent Expiries, Increased Uptake of Once-a-Day Fixed-dose Combination Drugs to Drive Growth”. The report provides insights into the Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome) HIV/AIDS therapeutics market including market forecasts ...  |  read more...
USD 3,500
Active Pharmaceutical Ingredients (APIs) Market in Asia Pacific to 2017 - Increasing Penetration in China and India Coupled with Low Cost Manufacturing to Fuel Regional Growth
11/9/2012 | published by: GBI Research
... in Asia Pacific to 2017 - Increasing Penetration in China and India Coupled with Low Cost Manufacturing to Fuel Regional Growth”, provides a detailed insight into the Asia-Pacific API market. The research presents detailed analysis ...  |  read more...
USD 3,500
Gastrointestinal Disorders Therapeutics Market to 2018 - Novel Agents Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) and Ulcerative Colitis (UC) to Reinvigorate the Market
11/1/2012 | published by: GBI Research
... its latest research, “Gastrointestinal Disorders Therapeutics Market to 2018 - Novel Agents Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) and Ulcerative Colitis (UC) to Reinvigorate the Market”, which provides insights into the gastrointestinal disorders ...  |  read more...
USD 3,500
Leukemia Therapeutics Market to 2018 - Strong Late-stage Pipeline to Sustain Branded Drugs' Major Market Share
11/1/2012 | published by: GBI Research
... Strong Late-stage Pipeline to Sustain Branded Drugs' Major Market Share” which provides insights into leukemia therapeutics market until 2018 for four major indications. The report is built using data and information sourced from proprietary databases, ...  |  read more...
USD 3,500
2  3  4  5    7    9  10  11  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!